One of the things that impresses me most about our life sciences industry is its ability to, in the face of economic and social pressures, maintain the integrity of giving back. In a world where the term 'big bad pharma' gets thrown about with abandon as a result of ballooning healthcare costs and governmental funding cuts, it's easy to forget just how many organisations are doing more not just in wealthier and developed countries but also in more destitute geographies around the world.
Companies of all sizes from Novartis, Abbvie and GSK to NovoNordisk, Gilead, BMS and Celgene (to name just a few) all have extensive outreach programmes which dedicate multi-millions of dollars annually to emerging market geographies in severely debilitating conditions such as HIV, malaria, diabetes, respiratory and eye diseases. And yet M&As, quarterly revenue reports and commercial woes always seem to take priority in news headlines. The corporate responsibility that these companies take on, and create whole departmental functions behind, is what distinguishes our industry from so many others.
Of course there are some organisations that do 'less' if anything at all in the outreach space but they tend to stand out like sore thumbs and you can often tell in your interactions with their management that they're more interested in the dollars rather than the sense.
That healthcare is essentially a business like any other, run with significant underlying costs and overt shareholder responsibilities, all with an aim towards cumulative profit is, or at least should be, a given. But the vision and commitment of organisations to the 'care' of human health is best reflected by how much they prioritise putting back in, not just through their commercial activity, but through their outreach programmes.
Cynics might argue that all outreach is essentially PR and as such commercially intended. To them I say go visit rural Uganda where a new and free eye clinic is being built to serve several thousands of residents, many whom have become blind with easily treatable conditions. It will sit alongside the free HIV clinic. Malaria has been virtually eradicated there. All at little or no cost to the government or the people. All in some way funded by our industry. If that's PR then that is exactly what PR should be - an attestation of the 'care' in healthcare!